[Plasmapheresis in the combined treatment of the extrapyramidal neuroleptic syndrome in schizophrenic patients].
The paper focuses on feasibility of employment of therapeutic plasmapheresis in a combined treatment of complications of psychopharmacotherapy. The use of the above-named approach permitted arresting the chief manifestations of protracted neuroleptic syndrome and succeed in achieving a substantial reduction of extrapyramidal symptomatology in chronic neuroleptic syndrome. The results secured suggest high efficiency of the proposed therapeutic programme and enable us to recommend it for a wide practical use.
Pishel'
V Ia
VIa
D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000209:etiology / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology / Q000628:therapy*; D010956:Plasmapheresis; D012074:Remission Induction; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy
D014150:Antipsychotic Agents